论文部分内容阅读
为了解人胎盘血丙种球蛋白(胎丙)对病毒性肝炎的疗效,本院从1974年8月至1979年1月应用胎丙治疗肝炎患者31例,其中慢肝26例(慢迁肝17例、慢活肝9例,病程已1.5～12年,平均3.9年)、急肝5例(黄疸型3例、无黄疸型2例);本院职工36例,其中长期有轻度肝炎症状者20例、患过肝炎者8例、肝炎恢复期6例、慢性HBsAg携带者2例。两组共男33例、女34例,年龄15～55岁。每天肌注上海生物制品研究所生产、经RIA法检查HBsAg阴性的胎丙一次3毫升(含丙球180毫克),连续14天为一疗程(22例)。或连续2疗程(27例)及3疗程(18例)。疗程结束后一律随访6个月。胎丙治疗期间不同时应用其他药物。
In order to understand the effect of human placental blood gamma globulin (fetal C) on viral hepatitis, our hospital from August 1974 to January 1979 application of fetal C treatment of hepatitis patients in 31 cases, of which 26 cases of chronic hepatitis Cases, slow living liver in 9 cases, duration of 1.5 to 12 years, an average of 3.9 years), acute liver in 5 cases (jaundice in 3 cases, no jaundice in 2 cases); hospital staff 36 cases, including long-term mild hepatitis symptoms 20 cases, 8 cases of hepatitis, 6 cases of recovery of hepatitis, 2 cases of chronic HBsAg carriers. A total of 33 males and 34 females, aged 15 to 55 years. Daily intramuscular injection of Shanghai Institute of Biological Products produced by the RIA method HBsAg-negative fetus C 3 ml (containing 180 mg propanil) for 14 days for a course of treatment (22 cases). Or continuous 2 courses (27 cases) and 3 courses (18 cases). Follow-up 6 months after treatment. Other drugs are not applied at the same time during fetal C treatment.